The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression.
Lilly, A Joshua
The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology Feb 2015 - 225-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1432-1912
10.1007/s00210-014-1027-8 doi
Animals
Disease Progression
Humans
Leukemia, Myeloid, Acute--metabolism
Mucin-1--metabolism
NM23 Nucleoside Diphosphate Kinases--metabolism
Receptors, Cell Surface--metabolism
The case for extracellular Nm23-H1 as a driver of acute myeloid leukaemia (AML) progression. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology Feb 2015 - 225-33 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1432-1912
10.1007/s00210-014-1027-8 doi
Animals
Disease Progression
Humans
Leukemia, Myeloid, Acute--metabolism
Mucin-1--metabolism
NM23 Nucleoside Diphosphate Kinases--metabolism
Receptors, Cell Surface--metabolism